Understanding barriers to transition from pediatric to adult care among young adults with sickle cell disease to develop a transition mentor program.
AS Viola, K Levonyan-Radloff… - Clinical Practice in …, 2021 - psycnet.apa.org
Objective: Patients with sickle cell disease require lifelong comprehensive care,
necessitating patient compliance with primary care appointments, specialty clinical visits …
necessitating patient compliance with primary care appointments, specialty clinical visits …
Feasibility of medical student mentors to improve transition in sickle cell disease
AS Viola, R Drachtman, A Kaveney… - Journal of pediatric …, 2021 - academic.oup.com
Objective Advances in medical care have resulted in nearly 95% of all children with sickle
cell disease (SCD) living to adulthood. There is a lack of effective transition programming …
cell disease (SCD) living to adulthood. There is a lack of effective transition programming …
Sickle Cell Disease: Lessons Learned
There is a national focus on transition from pediatric to adult healthcare. We propose a
framework to guide researchers, clinicians, healthcare administrators, and policymakers in …
framework to guide researchers, clinicians, healthcare administrators, and policymakers in …
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
Background Regularly transfused people with sickle cell disease (SCD) and people with
thalassaemia are at risk of iron overload. Iron overload can lead to iron toxicity in vulnerable …
thalassaemia are at risk of iron overload. Iron overload can lead to iron toxicity in vulnerable …
The Feasibility of a Medical Student Mentoring Program to Improve Transition of Care among Young Adults with Sickle Cell Disease
AS Viola - 2020 - search.proquest.com
Abstract In the United States, sickle cell disease (SCD) affects an estimated 100,000 people.
Although advances in treatment have resulted in up to 98% of patients surviving to 18 years …
Although advances in treatment have resulted in up to 98% of patients surviving to 18 years …